# 2D Materials & Van der Waals Heterostructures: State of the Field (October 2026)

Research dossier · v1 · updated 2026-10-30 · 3,054 words · 52 sources · 28 claims · verification: verified

Covers two-dimensional crystals and van der Waals heterostructures as of October 2026: stacking and twist-angle control, moire excitons and correlated superconductivity, two-dimensional magnets and ferroelectrics, and the fabrication limits that still constrain scale. The central takeaway is that stacking and twist engineering now produce strongly correlated and superconducting states in small devices, while wafer-scale growth, interface cleanliness and independent replication remain the bottleneck.

## Contents

- Executive summary
- Background and core concepts
- Timeline of key milestones
- State of the art
  - Moire and magic-angle bilayer graphene
  - Moire and interlayer excitons
  - Charge transport, spin and devices
  - Magnetism and ferroelectricity
  - Computational discovery and databases
  - Quantitative benchmarks
- Open problems and active debates
- Major programs and players
- Outlook: what to watch (near term)
- Key papers
- Glossary

## Sample findings

- Van der Waals heterostructures are built by stacking atomically thin crystals in a chosen order and relative twist, with weak interlayer bonding allowing layers with mismatched lattices to coexist.
- Magic-angle bilayer graphene, at a twist of about 1.1 degrees, shows a correlated insulating state at half filling of the moire flat band.

## Get the full dossier

GET https://space-kitty.com/api/v1/dossiers/2d-materials costs $0.20 via x402 (USDC on Base Sepolia (testnet)). Send `Accept: text/markdown` for Markdown or `application/json` for structured data (claims with citations, timeline, benchmarks, open problems, glossary, bibliography).
---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.